Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma

NCT05892185 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-06-07

No results posted yet for this study

Summary

The objective of this study is to evaluate the efficacy and safety of glaucoma device in the treatment of primary open-angle glaucoma.

Conditions

Interventions

DEVICE

GELA

GELA glaucoma implant

DEVICE

XEN

XEN gel stent implant

Sponsors & Collaborators

  • Mingche Biotechnology CO., LTD

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2024-01-12
Completion
2024-07-19

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05892185 on ClinicalTrials.gov